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Violence against women is not a new phenomenon, nor are its consequences to women’s physical, mental 
and reproductive health. What is new is the growing recognition that acts of violence against women are not 
isolated events but rather form a pattern of behaviour that violates the rights of women and girls, limits their 
participation in society, and damages their health and well-being. When studied systematically, as was done 
with this report, it becomes clear that violence against women is a global public health problem that affects 
approximately one third of women globally.
By compiling and analysing all available data from studies designed to capture women’s experiences of 
different forms of violence, this report provides the first such summary of the violent life events that many 
women experience. It documents not only how widespread this problem is, but also how deeply women’s 
health is affected when they experience violence.
This report marks a big advance for women’s health and rights. It adds to the momentum of the 57th 
session of the Commission on the Status of Women, which emphasized the need to address the root causes 
of violence against women and to strengthen multisectoral responses for women who have experienced 
violence. It also contributes to advocacy efforts such as the United Nations Secretary General’s campaign 
UNiTE to end violence against women.
Action is clearly needed, and the health sector has an especially important role to play, considering the 
serious health risks faced by women and their families. WHO’s new clinical and policy guidelines on the 
health sector response to violence against women provide specific evidence-based guidance that can help 
to strengthen the way health-care providers respond to women who have experienced violence. They also 
stress the importance of incorporating issues of violence into clinical training curricula, strengthening health 
systems to support women through direct services and multisectoral responses, identifying key entry points, 
such as sexual and reproductive health services and mental health services for addressing violence, and 
scaling up appropriate post-rape care responses.
No public health response is complete without prevention. Violence against women can and should be 
prevented. Promising programmes exist and many hinge on promoting gender equality so that the full 
potential of the world’s women and girls can be realized. Let this report serve as a unified call to action for 
those working for a world without violence against women.
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“There is one universal truth, applicable to all 
countries, cultures and communities: violence 
against women is never acceptable, never 
excusable, never tolerable.”
United Nations Secretary-General, Ban Ki-Moon 
(2008)1
Violence against women is a significant public 
health problem, as well as a fundamental violation 
of women’s human rights.
This report, developed by the World Health 
Organization, the London School of Hygiene 
and Tropical Medicine and the South African 
Medical Research Council presents the first global 
systematic review and synthesis of the body of 
scientific data on the prevalence of two forms 
of violence against women — violence by an 
intimate partner (intimate partner violence) and 
sexual violence by someone other than a partner 
(non-partner sexual violence). It shows, for the first 
time, aggregated global and regional prevalence 
estimates of these two forms of violence, 
generated using population data from all over the 
world that have been compiled in a systematic way. 
The report also details the effects of violence on 
women’s physical, sexual and reproductive, and 
mental health.
The findings are striking:
• overall, 35% of women worldwide have 
experienced either physical and/or sexual 
intimate partner violence or non-partner sexual 
violence. While there are many other forms of 
violence that women may be exposed to, this 
already represents a large proportion of the 
world’s women;
1. Secretary-General says violence against women never 
acceptable, never excusable, never tolerable, as he launches 
global campaign on issue. New York, United Nations Depart-
ment of Public Information, News and Media Division, 2008 (SG/
SM/11437 WOM/1665).
• most of this violence is intimate partner 
violence. Worldwide, almost one third (30%) of 
all women who have been in a relationship have 
experienced physical and/or sexual violence by 
their intimate partner. In some regions, 38% 
of women have experienced intimate partner 
violence;
• globally, as many as 38% of all murders of 
women are committed by intimate partners;
• women who have been physically or sexually 
abused by their partners report higher rates 
of a number of important health problems. For 
example, they are 16% more likely to have a 
low-birth-weight baby. They are more than 
twice as likely to have an abortion, almost twice 
as likely to experience depression, and, in some 
regions, are 1.5 times more likely to acquire 
HIV, as compared to women who have not 
experienced partner violence;
• globally, 7% of women have been sexually 
assaulted by someone other than a partner. 
There are fewer data available on the health 
effects of non-partner sexual violence. However, 
the evidence that does exist reveals that women 
who have experienced this form of violence 
are 2.3 times more likely to have alcohol 
use disorders and 2.6 times more likely to 
experience depression or anxiety.
There is a clear need to scale up efforts across 
a range of sectors, both to prevent violence 
from happening in the first place and to provide 
necessary services for women experiencing 
violence.
Executive summary
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The variation in the prevalence of violence seen 
within and between communities, countries and 
regions, highlights that violence is not inevitable, 
and that it can be prevented. Promising prevention 
programmes exist, and need to be tested and 
scaled up.2 There is growing evidence about what 
factors explain the global variation documented. 
This evidence highlights the need to address the 
economic and sociocultural factors that foster 
a culture of violence against women. This also 
includes the importance of challenging social 
norms that support male authority and control 
over women and sanction or condone violence 
against women; reducing levels of childhood 
exposures to violence; reforming discriminatory 
family law; strengthening women’s economic and 
legal rights; and eliminating gender inequalities in 
access to formal wage employment and secondary 
education.
Services also need to be provided for those who 
have experienced violence. The health sector 
must play a greater role in responding to intimate 
partner violence and sexual violence against 
women. WHO’s new clinical and policy guidelines 
on the health-sector response to violence against 
women emphasize the urgent need to integrate 
issues related to violence into clinical training. 
It is important that all health-care providers 
understand the relationship between exposure to 
violence and women’s ill health, and are able to 
respond appropriately. One key aspect is to identify 
opportunities to provide support and link women 
with other services they need – for example, 
when women seek sexual and reproductive health 
services (e.g. antenatal care, family planning, 
post-abortion care) or HIV testing, mental health 
2. Preventing intimate partner violence and sexual violence 
against women. Taking action and generating evidence. Geneva, 
World Health Organization, 2010.
and emergency services. Comprehensive post-
rape care services need to be made available and 
accessible at a much larger scale than is currently 
provided.
The report shows that violence against women is 
pervasive globally. The findings send a powerful 
message that violence against women is not a 
small problem that only occurs in some pockets of 
society, but rather is a global public health problem 
of epidemic proportions, requiring urgent action. 
It is time for the world to take action: a life free 
of violence is a basic human right, one that every 
woman, man and child deserves.
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There is growing recognition that violence against 
women has a large public health impact, in addition 
to being a gross violation of women’s human rights 
(1). This recognition is the result of international 
commitments to document the magnitude of the 
problem and its consequences and the ever-
expanding evidence base on the prevalence and 
consequences of this violence. The United Nations 
Secretary-General, Ban Ki-Moon, has issued a 
global call to action to end violence against women, 
by launching the UNiTE to End Violence against 
Women campaign. Most recently, the agreed 
conclusions of the 57th session of the Commission 
on the Status of Women (2) emphasize the 
importance both of addressing structural and 
underlying causes and risk factors in order to 
prevent violence against women and girls, and of 
strengthening multisectoral services, programmes 
and responses for victims and survivors. The 
agreed conclusions also call for continued 
multidisciplinary research and analysis on the 
causes of, and cost and risk factors for, violence 
against women and girls, in order to inform laws, 
policies and strategies and support awareness-
raising efforts.
The term “violence against women” encompasses 
many forms of violence, including violence by an 
intimate partner (intimate partner violence) and 
rape/sexual assault and other forms of sexual 
violence perpetrated by someone other than a 
partner (non-partner sexual violence), as well as 
female genital mutilation, honour killings and the 
trafficking of women.
This report focuses on two forms of violence 
against women: physical and/or sexual intimate 
partner violence and non-partner sexual violence. 
Over the past decade, there has been a rapid 
growth in the body of research evidence available 
on the prevalence of intimate partner violence 
and its health effects. This is, in part, a result of 
a growing consensus on how best to measure 
women’s exposure to intimate partner (and other 
forms of) violence through household surveys, 
while also taking precautions to put women’s 
safety first and to ensure that respondents 
requesting assistance can be referred to services if 
needed (3). As well as specialized surveys, national 
governments are increasingly incorporating 
questions on women’s exposure to partner violence 
into their national health surveys, including, for 
example, in the Demographic and Health Surveys 
(DHSs) (4 ) and the Centers for Disease Control 
and Prevention (CDC) reproductive health surveys 
(RHSs) (5 ).
Similarly, for sexual violence by perpetrators 
other than a partner (i.e., friends, acquaintances, 
strangers, other family members), there is a 
growing body of research evidence on levels of 
such violence, although this is much more limited 
than for intimate partner violence. There is growing 
consensus on how best to document exposure to 
sexual violence, although, in practice, definitions 
may vary between studies, and not all forms of 
sexual violence are well documented.
This report presents the first global systematic 
review and synthesis of the body of scientific data 
measuring the population prevalence of intimate 
partner violence against women, and non-partner 
sexual violence against women. It presents, for 
the first time, aggregated global and regional 
prevalence estimates of these two forms of 
violence, generated using population data from all 
over the world, compiled in a systematic way.
The report is divided into three sections, with a 
fourth summary and conclusions section. Section 1 
describes the methods used for calculating the 
global and regional prevalence estimates of 
intimate partner violence and non-partner sexual 
Introduction
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violence,3 and section 2 presents the global and 
regional prevalence estimates for each form of 
violence. Section 3 summarizes evidence on the 
magnitude of a range of health effects associated 
with exposure to either form of violence. These 
analyses are based on systematic reviews and 
data pooled across surveys, analysed using meta-
analysis where possible. This evidence shows that 
women experiencing intimate partner violence 
are significantly more likely to experience serious 
health problems than women who have not 
experienced such violence. The health effects of 
non-partner sexual violence are also presented, 
although fewer outcomes are included in this 
section because of the relative lack of research in 
this area.
This evidence shows that both intimate partner 
violence and non-partner sexual violence are 
widespread and that they have important effects 
on women’s physical, sexual and reproductive, and 
mental health. In combination, these findings send 
a powerful message that violence against women 
is not a small problem that only occurs in some 
pockets of society, but rather is a global public 
health problem of epidemic proportions, requiring 
urgent action.
Definitions and conceptual 
framework
Table 1 summarizes the working definitions for 
each form of violence used in this review.
3. The age of 15 years is set as the lower age limit for partner 
violence and non-partner sexual violence, so while we refer to 
“violence against women” throughout the report, we recognize 
that violence experienced by girls between the ages of 15 and 
18 years is also considered child maltreatment.
Health outcomes and causal 
pathways
While there has been an important growth during 
the past decade in the number of population-based 
studies globally that are starting to document the 
prevalence/magnitude of different forms of violence 
against women, there has been less research on 
the health effects of exposures to different forms 
of violence (6). However, what this literature does 
highlight is the extreme breadth in potential health 
effects – encompassing physical, sexual and 
reproductive, and mental health, with potentially 
large impacts on levels of women’s morbidity 
and mortality. This evidence comes from a few 
rigorous, prospective and carefully controlled 
clinical and epidemiological research studies, and, 
more commonly, from assessments of association 
using population-based cross-sectional data. As 
described in more detail below, although the field’s 
reliance on cross-sectional data is a limitation, 
the studies used are often large, representative, 
population-based surveys that have been replicated 
in multiple settings, with strong consistency of 
findings across studies.
The likely causal pathways between different 
forms of exposure to violence and different health 
outcomes are starting to be documented and 
understood better. These pathways are often 
complex, with context-specific, physiological, 
behavioural and other factors influencing the 
likelihood of disease/ill-health outcomes.
There is a broad range of health effects. Figure 1 
shows the hypothesized pathways through which 
intimate partner violence leads to different forms 
of morbidity and mortality. These include the direct 
pathway of violence resulting in injury and death, 
and the other direct and indirect pathways for 
multiple health problems for women, as well as 
maternal and perinatal health outcomes.
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Table 1. Working definitions of forms of exposure to violence used in this review
Term Definition for this review
Intimate partner 
violencea
Self-reported experience of one or more acts of physical and/or sexual violence by a 
current or former partner since the age of 15 years.b
∙ Physical violence is defined as: being slapped or having something thrown at you 
that could hurt you, being pushed or shoved, being hit with a fist or something 
else that could hurt, being kicked, dragged or beaten up, being choked or burnt 
on purpose, and/or being threatened with, or actually, having a gun, knife or other 
weapon used on you.
∙ Sexual violence is defined as: being physically forced to have sexual intercourse 
when you did not want to, having sexual intercourse because you were afraid of 
what your partner might do, and/or being forced to do something sexual that you 
found humiliating or degrading.c
Severe intimate 
partner violence
Is defined on the basis of the severity of the acts of physical violence: being beaten 
up, choked or burnt on purpose, and/or being threatened or having a weapon used 
against you is considered severe. Any sexual violence is also considered severe.
Current intimate 
partner violence
Self-reported experience of partner violence in the past year.
Prior intimate 
partner violence
Self-reported experience of partner violence before the past year.
Non-partner sexual 
violence
When aged 15 years or over,b experience of being forced to perform any sexual act 
that you did not want to by someone other than your husband/partner.
a The definition of intimate partner varies between settings and includes formal partnerships, such as marriage, as well 
as informal partnerships, including dating relationships and unmarried sexual relationships. In some settings, intimate 
partners tend to be married, while in others more informal partnerships are more common.
b The age of 15 years is set as the lower age range for partner violence and non-partner sexual violence. Intimate 
partner violence has only been measured for women who have reported being in a partnership, as they are the 
“at-risk” group. Therefore, for women between the ages of 15 and 18 years, only those who have been in a partnership, 
including dating relationships and marital relationships in settings where marriage occurs in this age group, could 
potentially report intimate partner violence. Young women in the age group 15–18 years experiencing non-partner 
sexual violence can also be considered, by some legal definitions, to have experienced child sexual abuse, as these are 
not mutually exclusive categories.
c The definition of humiliating and degrading may vary across studies, depending on the regional and cultural setting.
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A more indirect pathway, mediated by stress 
responses, is documented in a body of research 
that has expanded rapidly over the past two 
decades. This literature provides good evidence 
about the underlying biological (physiological) 
mechanisms of the association between exposures 
to violence and different adverse health outcomes, 
through complex and interconnected neural, 
neuroendocrine and immune responses to acute 
and chronic stress (7–9). For example, when 
exposed to prolonged or acute stress, areas of the 
brain such as the hippocampus, amygdala and 
prefrontal cortex undergo structural changes that 
have implications for mental health and cognitive 
functioning, and can lead to mental disorders, 
somatoform disorders or chronic illness, as well 
as other physical conditions (10). In response to 
stress, the immune system can be compromised, 
exacerbating the spread of cancer and viral 
infections. Sustained and acute elevated stress 
levels have also been linked to cardiovascular 
disease, hypertension, gastrointestinal disorders, 
chronic pain, and the development of insulin-
dependent diabetes (10). Stress during and around 
the time of pregnancy has been linked with low-
birth-weight infants, as rising cortisol levels lead 
to constriction of the blood vessels, limiting blood 
flow to the uterus. Furthermore, the hypothalamic–
pituitary–adrenal response can trigger premature 
labour and premature birth, through contractions of 
the smooth muscle tissue in the uterus (11, 12).
In addition to the biological stress response, 
there are behavioural and other risk factors that 
also influence the link between intimate partner 
violence and adverse health outcomes. Some 
women try to manage the negative consequences 
of abuse through the use of alcohol, prescription 
medication, tobacco or other drugs (13, 14). Each 
of these is an important risk factor for poor health, 
and part of the complex link between exposures to 
violence and other health risk factors that mediate 
negative health outcomes.
An additional, less documented, but emerging 
pathway relates to the psychological control 
that defines many relationships in which partner 
violence occurs. These controlling behaviours 
relate to a series of ways in which male partners 
might attempt to control and/or limit the behaviours 
and social interactions of their female partners 
(e.g., limiting social and family interactions, 
insisting on knowing where she is at all times, 
being suspicious of unfaithfulness, getting angry 
if she speaks with another man, expecting 
his permission for seeking health care). Such 
controlling behaviour often co-occurs with physical 
and sexual violence, and may be highly prevalent in 
violent relationships. Emerging evidence suggests 
that abusive partners who exhibit these behaviours 
can limit women’s ability to control their sexual 
and reproductive decision-making, their access 
to health care, or their adherence to medications, 
which can have adverse health effects.
As illustrated in Figure 1, the relationship between 
exposures to violence and health effects is 
complex. Intrinsic in many of these postulated 
associations is the assumption that there are 
intermediate pathways, such that violence might 
increase the tendency to a particular risk behaviour 
and that risk behaviour, in turn, increases the 
likelihood of an adverse health outcome. The data 
to date, however, are limited; they are mostly 
cross-sectional and do not allow temporality or 
causality to be determined. More and different 
kinds of research, such as longitudinal studies, 
inclusion of biomarkers to measure health 
outcomes, and properly controlling for potentially 
confounding variables affecting the associations 
found, are needed to be able to describe these 
pathways and associations more conclusively.
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Figure 1. Pathways and health effects on intimate partner violence 
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There are multiple pathways through which intimate partner violence can lead to adverse health outcomes. This figure highlights three 
key mechanisms and pathways that can explain many of these outcomes. Mental health problems and substance use might result 
directly from any of the three mechanisms, which might, in turn, increase health risks. However, mental health problems and substance 
use are not necessarily a precondition for subsequent health effects, and will not always lie in the pathway to adverse health.
PHYSICAL TRAUMA PSYCHOLOGICAL TRAUMA/ 
STRESS
FEAR AND CONTROL
INTIMATE PARTNER VIOLENCE
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This section of the report briefly describes the 
methods used for calculating the global and 
regional prevalence estimates of intimate partner 
violence and non-partner sexual violence.
Measurement of exposure to 
intimate partner violence and non-
partner sexual violence
There is growing consensus on how to measure 
exposures to different forms of interpersonal 
violence, with most work focusing on the 
measurement of violence by an intimate partner 
(15, 16). Gold standard methods to estimate the 
prevalence of any form of violence are obtained 
by asking respondents direct questions about 
their experience of specific acts of violence over 
a defined period of time, rather than using more 
generic questions about whether the respondent 
has been “abused” or has experienced “domestic 
violence” or “rape” or “sexual abuse”, which 
tends to yield less disclosure. Methodological 
issues related to the implementation of the survey 
procedures – including the selection and levels of 
training of interviewers, and ensuring appropriate 
support of respondents and interviewers, have 
also been shown to influence levels of disclosure 
(3, 17, 18).
Definitions of WHO regions
The focus of this review was to obtain both global 
and regional evidence on the prevalence of intimate 
partner violence and non-partner sexual violence. 
The regional assessments in this report were 
based upon the World Health Organization (WHO) 
regions, and included low- and middle-income 
countries in the Region of the Americas (Latin 
America and the Caribbean), the African Region, 
the Eastern Mediterranean Region, the European 
Region, the South-East Asia Region, and the 
Western Pacific Region, as well as a category for 
high-income countries from the different regions 
(See Appendix 1 for tables detailing the countries 
for which data are available in each region).
The global estimate for intimate partner violence 
and non-partner sexual violence is based on the 
regional weighted prevalence estimates using 
Global Burden of Disease (GBD) regions (19), since 
these regions are broken into finer categories that 
are more meaningful epidemiologically. Regional 
estimates for intimate partner violence and non-
partner sexual violence for these regions are 
included in Tables A2.1 and A2.2 in Appendix 2.
Prevalence estimates of intimate 
partner violence
Most population-based research to assess the 
prevalence of intimate partner violence focuses on 
compiling information on respondents’ exposures 
to a range of physical, sexual and emotional/
psychological acts of violence by a current or 
former intimate partner, whether cohabiting or not. 
Definitions of each of these aspects of violence 
are operationalized using behaviourally specific 
questions related to each type of violence, ranging 
from slaps, pushes and shoves, through to more 
severe acts, such as being strangled or burnt, hit 
with a fist, threatened with, or having, a weapon 
used against you. The Conflict Tactics Scale (CTS) 
(20) has been widely used in the United States of 
America (USA) and elsewhere to document the 
prevalence of physical partner violence, framing 
violent acts in the context of relationship conflict. 
The WHO multi-country study on women’s health 
and domestic violence against women (21) and 
the violence against women module of the DHS 
(22) are adapted versions of the CTS that also 
ask about a set of behaviourally specific acts that 
women experience, without framing the questions 
as gradations of relationship conflict, but rather as 
independent acts in a constellation of experiences 
Section 1: Methodology
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encompassing partner violence. These instruments 
have been applied in numerous settings and are 
considered valid and reliable measures of intimate 
partner violence.
In general, surveys on intimate partner violence 
ask respondents about their exposure ever (in their 
lifetime), and in the past year, with a few studies 
also asking about violence in the last month or 
within a particular relationship. This report focuses 
on assessing women’s lifetime exposure to physical 
or sexual violence, or both, by an intimate partner. 
This is defined as the proportion of ever-partnered 
women who reported having experienced one or 
more acts of physical or sexual violence, or both, 
by a current or former intimate partner at any point 
in their lives (See Table 1, footnote a for a definition 
of intimate partner). Current prevalence is defined 
as the proportion of ever-partnered women 
reporting that at least one act of physical or sexual 
violence, or both, took place during the 12 months 
prior to the interview.
It should be noted that intimate partner violence 
also includes emotional abuse (being humiliated, 
insulted, intimidated or threatened, for example) 
and controlling behaviours by a partner, such as 
not being allowed to see friends or family (23, 
24 ). This form of abuse also impacts the health of 
individuals. However, there is currently a lack of 
agreement on standard measures of emotional/
psychological partner violence and the threshold 
at which acts that can be considered unkind or 
insulting cross the line into being emotional abuse. 
For this reason, emotional/psychological violence 
has not been included in this analysis, and, for the 
purposes of this report, the measures of intimate 
partner violence solely include act(s) of physical 
and/or sexual violence.
Compilation of evidence on the 
prevalence of intimate partner 
violence
A systematic review of the prevalence of intimate 
partner violence was conducted, compiling 
evidence from both peer-reviewed literature and 
grey literature from first record to 2008; the 
peer-reviewed component was then updated to 
9 January 2011. For this, a search was conducted 
of 26 medical and social science databases in all 
languages, yielding results in English, Spanish, 
French, Portuguese, Russian, Chinese and a few 
other languages. Controlled vocabulary terms 
specific to each database were used (e.g. MeSH 
terms for Medline). Only representative population-
based studies with prevalence estimates for 
intimate partner violence in women of any 
age above 15 years were included. Any author 
definitions of intimate partner violence were 
included. A total of 7350 abstracts were screened. 
Additional analysis of the WHO multi-country study 
on women’s health and domestic violence against 
women (21) (10 countries) was also performed, and 
additional analyses of the International Violence 
Against Women Surveys (IVAWS, 8 countries) 
(25 ), GENACIS: Gender, alcohol and culture: an 
international study (16 countries) (26) and the DHS 
(20 countries) (4, 22) were also conducted. In 
total, 185 studies from 86 countries representing 
all global regions met our inclusion criteria, and 
data from 155 studies in 81 countries informed our 
estimates. Of these, 141 studies were used in the 
all ages model, 89 were used in the age-specific 
model, and 75 were used in both. Of the 14 studies 
used only in the age-specific model, nine had 
insufficient data for calculating an all-age estimate 
and five had a broader range of age specific data 
but were not included in the all-age estimate. 
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Sixty-six studies had prevalence data for a broad 
age band so were included in the all ages model 
but not in the age-specific model. 
The study focused on extracting data by age group 
on ever, and past-year, experience of physical 
and sexual violence for ever-partnered women, 
making note of the specific definitions used, as 
well as elements of the survey characteristics. 
Where a breakdown by the severity of violence was 
reported, these data were also compiled. For this, 
severe violence was categorized by the severity of 
the acts of physical violence, so that any severe 
acts experienced, such as being beaten up, choked 
or burnt on purpose, threatened with a weapon, or 
a woman having had a weapon used against her, 
as well as any act of sexual violence, would be 
considered severe violence.
Only studies with primary data from population 
surveys were included, and only women aged 
15 years and older were included. In some settings, 
girls are partnered formally or informally before the 
age of 15 years, but since most surveys capturing 
data on intimate partner violence, especially 
those from low- and middle-income countries, 
focus on women in the reproductive age group 
(15–49 years), 15 years was set as the lower age 
limit for data extraction. Intimate partner violence 
experienced by girls aged under 18 years can also 
be considered child abuse or maltreatment, and 
we stress the importance of recognizing that these 
are not mutually exclusive categories (See Table 1, 
footnote b).
Similarly, data on women aged over 49 years 
were scarce and tended to be from high-income 
countries. However, data were extracted for older 
age categories, where these had been collected. 
Tables A1.3 and A1.4 in Appendix 1 show the 
distribution of studies by age group and for all ages 
by region for data on intimate partner violence.
Intimate partner violence against older women is 
a form of elder maltreatment, and, as is the case 
with child maltreatment, the categories of intimate 
partner violence and elder maltreatment are not 
mutually exclusive. Violence against children 
and the elderly are important areas of research 
that merit further investigation and careful 
consideration of the special methodological and 
safety concerns inherent in research among these 
populations.
Compilation of evidence on the 
prevalence of non-partner sexual 
violence
A systematic search was used to compile evidence 
on the prevalence of non-partner sexual violence. 
For this, a systematic search of biomedical 
databases was carried out (British Medical 
Journal, British Nursing Index, Cumulative Index 
to Nursing and Allied Health Literature [CINAHL], 
Cochrane Library, Embase, Health Management 
Information Consortium, Medline, PubMed, Science 
Direct, Wiley-Interscience), as well as social 
sciences databases (International Bibliography 
of Social Sciences, PsychINFO, Web of Science) 
and international databases (ADOLEC, African 
Healthline, Global Health, Index Medicus for the 
WHO Eastern Mediterranean Region (IMEMR), 
Index Medicus for the South-East Asian Region 
(IMSEAR) and the Western Pacific Region Index 
Medicus (WPRIM), LILACS, Medcarib, Popline) 
for studies published from 1998 to 2010. An 
independent search was also conducted of 
international surveys on violence against women 
or surveys that included questions on exposure 
to non-partner sexual violence. Specific data sets 
included: IVAWS (25); the WHO multi-country study 
on women’s health and domestic violence against 
women (21); DHS (4, 22); GENACIS (26); CDC RHS 
(5 ) and crime surveys across the globe. Citations 
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were also followed up and contact was made with 
experts, giving special attention to studies from 
conflict settings, to identify additional studies.
Studies with primary data on population-based 
estimates of non-partner sexual violence were 
included and non-population-based studies were 
only considered in regions where population 
data were limited. Only women aged 15 years 
and older were included, to differentiate violence 
against women from child sexual abuse and to be 
consistent with the estimates of intimate partner 
violence. We again acknowledge, however, that 
sexual violence occurring between the ages of 
15 and 18 years is also considered child sexual 
abuse and that these categories are not mutually 
exclusive.
Data on lifetime and current (past year) exposure to 
non-partner sexual violence were extracted, but it 
was generally found that current exposure to non-
partner sexual violence was reported rarely. The 
way in which perpetrators were defined in studies 
was critical in assessing inclusion. For exposure, 
sexual violence by all perpetrators other than 
intimate partners (e.g., strangers, acquaintances, 
friends, family members, colleagues, police, 
military personnel, etc.) was relevant to the 
analysis. Many studies combined perpetrators 
(intimate partners and non-partner perpetrators) 
in the analysis, and studies where intimate partner 
perpetrators could not be separated from non-
partners were excluded in order to avoid double 
counting of acts captured in the analysis of intimate 
partner violence. For example, many crime surveys 
(European Survey of Crime and Safety) (27 ) and 
International Crime Victim Survey (28) presented 
data on sexual victimization, without differentiating 
perpetrators.
Some studies only reported on single perpetrators, 
such as strangers, while many combined non-
partner perpetrators. To prevent double counting 
and overlapping of estimates from studies where 
estimates were provided for multiple single 
perpetrators (stranger, acquaintance, family 
member), the estimate based on the largest sample 
was chosen.
Estimates based on any author’s definition of 
sexual violence were included. Unlike intimate 
partner violence, most studies used a single broad 
question such as “Have you ever been forced to 
have sex or to perform a sexual act when you 
did not want to with someone other than your 
partner?”, which is known to underestimate 
prevalence. To prevent double counting, estimates 
from the same study/author were checked and the 
most relevant paper/estimates were included.
The majority of the study estimates (87%) were 
derived from three large international data sets:  
the WHO multi-country study on women’s health 
and domestic violence against women (21)  
(10 countries), IVAWS (25 ) (8 countries) and 
GENACIS (26) (16 countries). All three studies 
used a single question to capture exposure to 
non-partner sexual violence since the age of 15 
years. All the available DHSs were reviewed (4 ) and 
since only eight of the 48 surveys provided data on 
sexual violence by non-partners, only these eight 
surveys could be included.
Sexual violence during conflict perpetrated by 
militia, military personnel or police is an important 
aspect of non-partner sexual violence. Only six 
population studies were identified that reported 
on non-partner sexual violence in conflict-affected 
settings. Many other studies report on sexual 
violence, as described in a recent review – but 
few of them are population-based studies or they 
do not separate partner and non-partner sexual 
violence (29). In this review, two of the studies in 
conflict settings were part of larger multi-country 
studies: the Philippines was part of the IVAWS (25 ) 
and Sri Lanka was part of the GENACIS project 
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(26), while the others (29–34 ) were studies 
dedicated to measuring experiences of violence 
during conflict.
A total of 7231 abstracts/records were identified 
for screening and the main reasons for exclusion 
were incorrect study design/non-population studies 
and studies focused on intimate partner violence 
or combining perpetrators. A total of 189 records/
abstracts were identified for full-text screening 
and, after assessment, 77 studies covering 56 
countries were included, producing 412 estimates 
from 347 605 participating women aged 15 
years and older. Data were found for five of the 
six WHO regions, with no data identified for the 
WHO Eastern Mediterranean Region. Table A1.2 
in Appendix 1 shows a list of the 56 countries and 
territories for which data were available.
During data extraction, prevalence estimates 
were compiled by age group, and data on key 
methodological issues related to the context of 
the study (such as in a conflict setting), or study 
methods (including the question used to ask 
about sexual violence) were included. In practice, 
more than half (59.7%) of the estimates were 
derived from dedicated studies on violence against 
women, and 83.7% were from the three major 
multi-country studies (WHO, IVAWS, GENACIS). 
The majority of estimates measured lifetime non-
partner sexual violence (81.8%), combined non-
partner perpetrators of sexual violence (93.7%), 
and used a broad definition of sexual violence 
(91.5%).
Methods to obtain regional and 
global prevalence estimates of 
intimate partner violence and non-
partner sexual violence
Using estimates from all of these data sources, 
separately for both intimate partner violence and 
non-partner sexual violence, a random effects 
meta-regression (the metareg command version 
sbe23_1 using residual maximum likelihood with 
a Knapp–Hartung modification to the variance 
of the estimated coefficients, Stata 12.1) (35, 
36) was fitted to produce adjusted prevalence 
estimates for all WHO regions and by age groups 
(only for intimate partner violence) (37 ). The 
estimates of intimate partner violence were 
adjusted for differences in definitions of violence 
(physical or sexual or both), time periods of 
measurement (lifetime versus current), severity 
of violence (whether moderate or severe), and 
whether a study was national or subnational 
(national models being more generalizable) (see 
Appendix 3 for model descriptions). The covariates 
adjusted for in the model for non-partner sexual 
violence included whether fieldworkers were 
trained (interviewers specially trained in violence 
research tend to elicit more reliable responses 
from respondents as opposed to those who do 
not receive the specialized training), whether 
the study was a national study (and therefore 
more generalizable to the population of the 
country as a whole), and whether the respondent 
was given a choice of multiple perpetrators as 
opposed to a single perpetrator (multiple response 
options yield more accurate disclosure). More 
details on the methodology are provided in two 
forthcoming papers on the prevalence of intimate 
partner violence and non-partner sexual violence 
respectively (37, 38).
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WHO region was included in the model as a 
dummy variable, producing adjusted regional 
estimates (See Appendix 1 for countries included 
in each of the WHO regions for which data were 
available). In a second step of the analysis, using 
regional estimates derived from regression models 
developed for the Global Burden of Disease regions 
(See Appendix 2.1), as described elsewhere (37 ), 
the global estimate was calculated by weighting 
the GBD regional estimates together, based on the 
United Nations statistics for the total population 
of women aged 15–49 years for each region in 
2010 (39). The GBD regions, as opposed to the 
WHO regions, were used to calculate the global 
prevalence, because the high-income category of 
the WHO regions comprised countries from multiple 
geographic regions, which affected the population 
weighting for the remaining countries in each of 
the WHO regions and resulted in a weighted global 
prevalence estimate that differed very slightly (by 
less than 1%) from the global prevalence derived 
from the GBD regions.
For intimate partner violence, only studies of 
ever-partnered women were included. The 
estimates were then adjusted such that they 
reflected the proportion of the total population of 
women experiencing intimate partner violence, 
by multiplying the estimates by the age and 
study year and the country-specific proportion 
of women who had ever had sexual intercourse, 
which was assumed to be a proxy for “ever-
partnered” (personal communication, S Lim, 
Associate Professor of Global Health, Institute for 
Health Metrics and Evaluation at the University of 
Washington, 2013).
For intimate partner violence, only the studies 
reporting estimates for “all ages” were included in 
the regional prevalence estimates, while for non-
partner sexual violence, age-specific estimates 
were also included if no data for “all ages” were 
reported for the particular study.
Age-group-specific prevalence rates were 
estimated for intimate partner violence, but not for 
non-partner sexual violence, owing to the limited 
number of studies with prevalence estimates by 
age for non-partner sexual violence. Included 
age-group-specific estimates were categorized 
into the following age groups: 15–19, 20–24, 
25–34, 35–44, 45–54, 55–64, 65–74, 75–84 
and 85+ years. To obtain the global age group 
specific estimates the regional estimates were 
weighted together based on the regional female 
population size for the year 2010 (37, 38). Region-
specific age-group estimates were produced by 
combining the dummy variable for region and 
the dummy variable for age group, obtaining all 
unique combinations. Global age-group-specific 
estimates were finally obtained by weighting the 
regional age-group estimates by the total regional 
population of women in that age group. It should be 
noted that the age-specific estimates and the “all 
ages” estimate do not correspond to each other or 
to any region since age-specific estimates were 
calculated using studies reporting age-specific 
results, and results for “all ages” were calculated 
including only those studies explicitly reporting an 
estimate for “all ages”.
An estimate of the combined proportion of physical 
and/or sexual intimate partner violence and non-
partner sexual violence was calculated by using 
data from the regional prevalence results presented 
in this report for non-partner sexual violence and 
for the regional prevalence results of intimate 
partner violence among all women. The proportion 
Prevalence and health effects of intimate partner violence and non-partner sexual violence 15
of all women who had experienced physical or 
sexual intimate partner violence and/or non-partner 
sexual violence for each region was calculated 
using the following formula:
a*(100–c)+b
where a is the proportion of all women who had 
experienced intimate partner violence, from 
the prevalence estimates for all women (results 
presented in the report for intimate partner 
violence are among ever partnered women but 
for the combined estimate are for all women); b is 
the proportion of women who had experienced 
non-partner sexual violence, from the prevalence 
estimates; and c is the proportion of women who 
had experienced both intimate partner physical 
and sexual violence and non-partner sexual 
violence. The relative proportion of women who 
had experienced intimate partner violence and 
had also experienced non-partner sexual violence 
(c) was calculated using regional data from the 
original 10 countries (15 sites) participating in the 
WHO multi-country study on women’s health and 
domestic violence against women (21), in which 
questions on both intimate partner violence and 
non-partner sexual violence were asked of the 
same women. Global estimates were calculated 
using population weights for the WHO regions, 
resulting in a global prevalence that shows the 
proportion of women who had experienced intimate 
partner violence or non-partner sexual violence, or 
both.
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Table 3 shows the lifetime prevalence of intimate 
partner violence by age groups among ever-
partnered women. What is striking is that the 
prevalence of exposure to violence is already 
high among young women aged 15–19 years, 
suggesting that violence commonly starts early 
in women’s relationships. Prevalence then 
progressively rises to reach its peak in the age 
group of 40–44 years. The reported prevalence 
among women aged 50 years and older is lower, 
although the confidence intervals around these 
estimates are quite large, and a closer examination 
of the data reveals that data for the older age 
groups come primarily from high-income countries 
(see Table A1.3 in Appendix 1). Since most of 
the surveys on violence against women or other 
surveys with a violence module, such as the DHS 
or RHS, are carried out on women aged 15 or 18 
to 49 years, fewer data points are available for the 
over-49 age group. For this reason, it should not 
be interpreted that older women have experienced 
lower levels of partner violence, but rather that less 
is known about patterns of violence among women 
aged 50 years and older, especially in low- and 
middle-income countries.
Global and regional prevalence 
estimates of intimate partner 
violence
This section presents the global and regional 
prevalence estimates of intimate partner violence 
and non-partner sexual violence. This is the first 
time that such a comprehensive compilation of all 
available global data has been used to obtain global 
and regional prevalence estimates. Estimates are 
based on data extracted from 79 countries and two 
territories.
The global prevalence of physical and/or sexual 
intimate partner violence among all ever-partnered 
women was 30.0% (95% confidence interval 
[CI] = 27.8% to 32.2%). The prevalence was 
highest in the WHO African, Eastern Mediterranean 
and South-East Asia Regions, where approximately 
37% of ever-partnered women reported having 
experienced physical and/or sexual intimate 
partner violence at some point in their lives 
(see Table 2). Respondents in the Region of the 
Americas reported the next highest prevalence, 
with approximately 30% of women reporting 
lifetime exposure. Prevalence was lower in the 
high-income region (23%) and in the European and 
the Western Pacific Regions, where 25% of ever-
partnered women reported lifetime intimate partner 
violence experience (see Figure 2).4
The global lifetime prevalence of intimate partner 
violence among ever-partnered women is 30.0% 
(95% CI = 27.8% to 32.2%.)
4. More recent studies from the Western Pacific Region using 
the WHO study methodology have since been published, but 
were not available at the time the data were compiled. They 
show very high prevalence rates of physical and/or sexual inti-
mate partner violence between 60% and 68% (40–42). 
Section 2: Results – lifetime prevalence estimates
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Table 2. Lifetime prevalence of physical and/or sexual intimate partner  
violence among ever-partnered women by WHO region
WHO region Prevalence, % 95% CI, %
Low- and middle-income regions:
   Africa 36.6 32.7 to 40.5
   Americas 29.8 25.8 to 33.9
   Eastern Mediterranean 37.0 30.9 to 43.1
   Europe 25.4 20.9 to 30.0
   South-East Asia 37.7 32.8 to 42.6
   Western Pacific 24.6 20.1 to 29.0
High income 23.2 20.2 to 26.2
CI = confidence interval.
Table 3. Lifetime prevalence of intimate partner violence by age group  
among ever-partnered women
Age group, years Prevalence, % 95% CI, %
15–19 29.4 26.8 to 32.1
20–24 31.6 29.2 to 33.9
25–29 32.3 30.0 to 34.6
30–34 31.1 28.9 to 33.4
35–39 36.6 30.0 to 43.2
40–44 37.8 30.7 to 44.9
45–49 29.2 26.9 to 31.5
50–54 25.5 18.6 to 32.4
55–59 15.1 6.1 to 24.1
60–64 19.6 9.6 to 29.5
65–69 22.2 12.8 to 31.6
CI = confidence interval.
Section 2: Results – lifetime prevalence estimates
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Global and regional prevalence 
estimates of non-partner sexual 
violence
The adjusted lifetime prevalence of non-partner sexual 
violence by region, based on data from 56 countries and 
two territories, is presented in Table 4. Globally, 7.2%
(95% CI = 5.3% to 9.1%) of women reported ever having
experienced non-partner sexual violence. There were
variations across the WHO regions. The highest lifetime
prevalence of non-partner sexual violence was reported 
in the high-income region (12.6%; 95% CI = 8.9% to 
16.2%) and the African Region (11.9%; 95% CI = 8.5%
to 15.3%), while the lowest prevalence was found for the
South-East Asia Region (4.9%; 95% CI = 0.9% to 8.9%).
These differences between regions may arise for many
reasons, and need to be interpreted with caution,
especially as most of the regional estimates have wide 
confidence intervals. As well as real differences in the 
prevalence of non-partner sexual violence, the figures
are likely to be subject to differing degrees of under-
reporting by region. Sexual violence remains highly 
stigmatized in all settings, and even when studies take 
great care to address the sensitivity of the topic, it is
likely that the levels of disclosure will be influenced 
by respondents’ perceptions about the level of stigma
associated with any disclosure, and the perceived 
repercussions of others knowing about this violence.
The global lifetime prevalence of non-partner
sexual violence is 7.2% (95% CI = 5.3% to 9.1%).
Age-specific prevalence rates are not included because
of the lack of availability of age-specific data.
Figure 2. Global map showing regional prevalence rates of intimate partner violenceby WHO region* (2010)
* Regional prevalence rates are presented for each WHO region including low- and middle-income countries, with high income 
countries analyzed separately. See Appendix 1 for list of countries with data available by region.
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Table 4. Lifetime prevalence of non-partner sexual violence by WHO region
WHO region Prevalence, %a 95% CI, %
Low- and middle-income regions:
   Africa 11.9 8.5 to 15.3
   Americas 10.7 7.0 to 14.4
   Eastern Mediterraneanb – –
   Europe 5.2 0.8 to 9.7
   South-East Asia 4.9 0.9 to 8.9
   Western Pacific 6.8 1.6 to 12.0
High income 12.6 8.9 to 16.2
CI = confidence interval.
a Results adjusted for interviewer training, whether the study was national and whether response options were broad 
enough to allow for different categories of perpetrators or were limited to a single category of perpetrator.
b No data were found for countries in this region, therefore a prevalence estimate is not provided
population as well as in conflict-affected settings. 
As compared to intimate partner violence, fewer 
studies include questions on non-partner sexual 
violence, there are more regions and countries 
for which no data are available, and it is not 
clear whether the questions being used generate 
accurate disclosure. While both forms of violence 
remain stigmatized, which impacts reporting, 
in many settings sexual violence is even more 
stigmatized, resulting in self-blame and shame, 
and disclosure may even put women’s lives at 
risk. In addition, the measurement of intimate 
partner violence is more advanced than that of 
non-partner sexual violence, and there is more 
agreement among researchers on how to measure 
it.
Although we are aware that the data for non-
partner sexual violence were not as robust or 
extensive as for intimate partner violence, it is 
likely that the differences in prevalence of non-
partner sexual violence as compared to intimate 
partner violence reflect actual differences. It 
appears that intimate partner violence, which 
The prevalence of non-partner sexual violence 
among conflict-affected countries is an important 
aspect of the analysis, and data specific to conflict 
settings were identified (25, 26, 30–34, 43). 
However, these data were not analysed separately 
because data were only available from six conflict-
affected countries and there was a high amount 
of variability in the sampling methodology, with 
several of the studies using population-based 
surveys of the entire country and others sampling 
specifically in conflict-affected regions. The 
lowest prevalence was reported from estimates 
from two large multi-country studies (IVAWS and 
GENACIS), while the higher prevalence estimates 
were from studies that focused on measuring 
violence in conflict-affected settings. It is often 
difficult to conduct population-based studies in 
conflict-affected settings, and obtaining a truly 
representative sample may be difficult because of 
logistical or security issues.
This review brings to light the lack of data on 
non-partner sexual violence in the general 
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includes sexual violence, is considerably more 
prevalent and more common than non-partner 
sexual violence, as shown consistently in all 
regions.
When considering non-partner sexual violence 
in the context of violence against women and 
interpersonal violence in general, it appears that 
sexual violence is normative in settings where 
violence is common. As was seen in the WHO 
multi-country study on women’s health and 
domestic violence against women (21), certain 
countries that had higher levels of non-partner 
sexual violence (Namibia and the United Republic of 
Tanzania), compared to others that had lower levels 
(Ethiopia), tended also to have higher rates of other 
forms of violence, such as sexual abuse during 
childhood (a form of non-partner sexual violence) 
and men fighting with other men.
Table 5. Lifetime prevalence of intimate partner violence (physical and/or sexual) or  
non-partner sexual violence or both among all women (15 years and older) by WHO region
WHO region Proportion of women reporting intimate partner 
violence and/or non-partner sexual violence, %
Low- and middle-income regions:
Africa 45.6
Americas 36.1
Eastern Mediterranean 36.4
Europe 27.2
South-East Asia 40.2
Western Pacific 27.9a
High income 32.7
a More recent studies from the Western Pacific Region using the WHO study methodology have since been published, 
but were not available at the time the data were compiled. They show very high prevalence rates of physical and/or 
sexual intimate partner violence between 60% and 68% (40–42).
Combined estimates of the 
prevalence of intimate partner 
violence and non-partner violence
Globally, 35.6% of women have ever experienced 
either non-partner sexual violence or physical or 
sexual violence by an intimate partner, or both.
While there are many other forms of violence that 
women are exposed to, the two forms studied 
here together represent a large proportion of 
the violence women experience globally. The 
global combined estimate demonstrates just how 
common physical and sexual violence is in the lives 
of many women.
Regional estimates show prevalence rates of 
intimate partner violence and non-partner sexual 
violence combined ranging from 27.2% to 45.6% 
(see Table 5).
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New systematic reviews were conducted on 
a broad range of health effects of exposure to 
intimate partner violence and non-partner sexual 
violence. For each of these reviews, extensive 
searches of electronic databases were carried 
out, including African Healthline, Applied Social 
Sciences Index and Abstracts, British Medical 
Journal, British Nursing Index, the Cochrane 
Library, CINAHL, Embase, Health Management 
Information Consortium, IMEMR, IMSEAR, 
International Bibliography of Social Sciences, 
LILACS, MedCarib, Midwives Information and 
Resource Service, NHS Library for Health Specialist 
Libraries, Ovid Medline, Popline, PsychINFO, 
PubMed, Science Direct, Web of Science, Wiley 
InterScience and WPRIM.
These reviews sought to include all published 
and unpublished studies that provided data on 
the strength of association between the different 
forms of violence considered and each health 
outcome. In general, no restriction on language or 
year of publication was specified. Cross-sectional, 
case-control and cohort studies in any population 
were eligible for review. All author definitions 
of violence were included, and the measures of 
exposures used were recorded, along with other 
indicators of the study’s quality, and details of the 
factors controlled for in the analyses. In each case, 
relevant data were extracted using a standardized 
form. Random effects meta-analyses were used 
to generate pooled odds ratios for intimate partner 
violence where appropriate. For the health effects 
of non-partner sexual violence, pooled odds 
ratios were not generated, as there was too much 
variation in the definitions and measurements 
used. In these cases, best estimates from the 
literature are presented instead.
Health effects of exposure to 
intimate partner violence
This section describes the magnitude of the 
association between intimate partner violence and 
selected health outcomes: incident HIV infection, 
incident sexually transmitted infections (STIs), 
induced abortion, low birth weight, premature 
birth, growth restriction in utero and/or small 
for gestational age, alcohol use, depression 
and suicide, injuries, and death from homicide 
(Figure 1).
It is important to note that the selected outcomes 
presented here do not reflect the full range of 
health effects of exposure to intimate partner 
violence. For those that were chosen for this 
analysis, reasons included that there was at 
least some evidence from longitudinal studies, 
and sufficient published or raw data available to 
conduct a robust analysis in multiple settings, 
with at least some of the evidence coming from 
low- or middle-income countries; at least one 
of the studies included in the meta-analysis 
demonstrating a temporal order, with the violence 
clearly preceding the health risk; and plausible 
pathways of causality and mechanisms by which 
intimate partner violence can cause the selected 
outcome described in the literature. Results of the 
included health effects are summarized in Table 6 
near the end of this section.
Other physical, mental and sexual and reproductive 
health effects have been linked with intimate 
partner violence, and merit similar attention, 
despite their exclusion from this report. These 
include adolescent pregnancy, unintended 
pregnancy in general, miscarriage, stillbirth, 
intrauterine haemorrhage, nutritional deficiency, 
abdominal pain and other gastrointestinal 
problems, neurological disorders, chronic pain, 
disability, anxiety and post-traumatic stress 
Section 3: Results – the health effects of intimate partner 
violence and non-partner sexual violence
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disorder (PTSD), as well as noncommunicable 
diseases such as hypertension, cancer and 
cardiovascular diseases. In addition, there is 
evidence linking intimate partner violence with 
negative child health and development outcomes, 
but these are not included in this report.
HIV and other sexually transmitted 
infections
Over the past decade, there has been growing 
recognition that intimate partner violence is an 
important contributor to women’s vulnerability 
to HIV and STIs (45–49). The mechanisms 
underpinning a woman’s increased vulnerability 
to HIV or STIs include direct infection from forced 
sexual intercourse, as well as the potential 
for increased risk from the general effects of 
prolonged exposure to stress (49, 50). Women in 
violent relationships, or who live in fear of violence, 
may also have limited control over the timing or 
circumstances of sexual intercourse, or their ability 
to negotiate condom use (51). Partner violence may 
also be an important determinant of separation, 
which in turn may increase a woman’s risk of HIV 
if she acquires a new partner. Furthermore, there 
is behavioural evidence that men who use violence 
against their female partners are more likely 
than non-violent men to have a number of HIV-
risk behaviours, including having multiple sexual 
partners (52), frequent alcohol use (53), visiting 
sex workers (54), and having an STI (55, 56), all of 
which can increase women’s risk of HIV.
Forty-one studies were identified for inclusion in 
the review commissioned for this report (57 ). These 
included cohort, case-control and cross-sectional 
studies. The strongest evidence comes from cohort 
studies that use biological outcome measures, and 
allow determination of whether violence precedes 
incident HIV/STI infection. For this reason, although 
all of the evidence found was extracted, the 
analysis placed the most emphasis on the findings 
from cohort studies. Through the search, five 
cohort studies were found. Four of these explored 
the relationship between exposure to intimate 
partner violence and incident HIV or other STI 
infection. Two estimates looking at HIV infection 
and incident partner violence were also obtained. 
It was not possible to pool the findings because 
different measures were reported in different 
studies; we therefore propose best estimates 
based on the available studies. Of the studies of 
incident HIV/STI, the three large studies (58–60) 
( > 1000 participants) (two on HIV from sub-
Saharan Africa and one on STI from India) found 
an increased risk of HIV/STI among those reporting 
partner violence. The fourth study (61), among 
women attending substance-use treatment clinics 
in the USA, used self-reported data on HIV and STI 
diagnosis, and found some evidence of a lower 
risk of HIV among those reporting intimate partner 
violence. The two studies looking at incident 
intimate partner violence (61, 62) (after HIV or STI 
diagnosis) found inconsistent results. The best 
estimates of association between intimate partner 
violence and HIV/STIs are odds ratio (OR) = 1.52 
(95% CI = 1.03 to 2.23) for HIV (58); adjusted 
odds ratio (aOR) = 1.61 (95% CI = 1.24 to 2.08) 
for syphilis (63), and OR = 1.81 (95% CI = 0.90 to 
3.63) for chlamydia or gonorrhea (59).
The review findings highlight the need for further 
research. Larger and more representative cohort 
studies from Africa and India show an association 
between experience of intimate partner violence 
and biologically confirmed incident HIV/other STIs. 
However, one smaller, lower-quality cohort study 
from a population with high competing risks for HIV 
infection showed an inverse relationship. Evidence 
from a broader range of settings is needed, 
to assess the degree to which the association 
between exposure to violence and incident HIV is 
also found in other HIV epidemic settings.
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Induced abortion
Violent relationships are frequently marked by fear 
and controlling behaviours by partners, so it is not 
surprising that women in these relationships report 
more adverse sexual and reproductive health 
outcomes. The higher rates of adverse reproductive 
events can be explained by direct consequences of 
sexual violence and coercion, as well as by more 
indirect pathways affecting contraceptive use, such 
as sabotage of birth control, disapproval of birth 
control preventing use of contraception, or inability 
to negotiate condom use for fear of violence (64 ). 
As a result, women in abusive relationships have 
more unintended pregnancies (65–67 ). Of the 
estimated 80 million unintended pregnancies 
each year, at least half are terminated through 
induced abortion (68) and nearly half of those take 
place in unsafe conditions (69). While unintended 
pregnancies carried to term have been associated 
with health risk to mothers and infants, illegal and 
unsafe abortions place women’s health at even 
greater risk.
Analysis of data from 31 studies provides strong 
evidence that women with a history of intimate 
partner violence are more likely to report having 
had an induced abortion (pooled OR = 2.16, 95% 
CI = 1.88 to 2.49). Similar results were found in 
a subanalysis of five studies in which it could be 
confirmed that intimate partner violence preceded 
the abortion (OR = 2.38, 95% CI = 1.93 to 2.84). 
The effect of other factors, such as the timing 
of violence and legality of abortion were also 
explored, and explain some of the heterogeneity in 
estimates (70).
The review confirmed that higher rates of induced 
abortion among women with a history of intimate 
partner violence are consistently found in a variety 
of study designs and among diverse population 
groups. Sensitive and stigmatized events, such as 
abortion, tend to be underreported, particularly 
in settings where it is illegal, but the inclusion of 
case-control studies involving abortion patients 
provided important evidence of association. These 
findings emphasize the importance of addressing 
intimate partner violence in health settings, 
particularly in sexual and reproductive health 
services. 
Low birth weight and prematurity
Low birth weight can result from either preterm 
birth or growth restriction in utero, both of which 
can be directly linked to stress. Living in an abusive 
and dangerous environment marked by chronic 
stress can therefore be an important risk factor for 
maternal health, as well as affecting birth weight.
All observational studies (cohort, case-control, and 
cross-sectional) that investigated intimate partner 
violence and the potential association with low 
birth weight/preterm birth/growth restriction in 
utero were considered. Only studies for which the 
perpetrator was limited to the intimate partner and 
for which violence was limited to physical and/or 
sexual were eligible for review. Low birth weight 
was defined as < 2500 g, preterm birth was 
defined as gestational age of less than 37 weeks, 
and growth restriction in utero and/or small for 
gestational age was defined as birth weight below 
the tenth percentile.
A total of 17 studies met the inclusion criteria 
(13 low birth weight, 10 preterm birth, 3 growth 
restriction in utero). Intimate partner violence 
was positively associated with low birth weight 
(aOR = 1.16, 95% CI = 1.02 to 1.29), as was 
preterm birth (aOR = 1.41, 95% CI = 1.21 to 
1.62), even after adjusting for confounding 
factors. No statistically significant association 
was found between intimate partner violence and 
intrauterine growth restriction (aOR = 1.36, 95% 
CI = 0.53 to 2.19). Heterogeneity scores were 
24 Global and regional estimates of violence against women
statistically significant in the analysis of low birth 
weight, but they were much lower for growth 
restriction in utero and preterm birth (71).
Given the known causal mechanisms of stress-
related responses affecting birth weight and the 
consistent positive association found, these results 
suggest that intimate partner violence is indeed an 
important risk factor for having low-birth-weight 
babies.
Harmful alcohol use
Harmful use of alcohol and violence are 
intertwined. As well as alcohol being an important 
facilitator of men’s use of violence, there is also 
evidence of an association for women between 
violence and frequent alcohol use. The nature of 
this association is likely to be complex. Women 
may drink alcohol to cope with the sequelae of 
abuse, but, conversely, women’s consumption of 
alcohol may result in abuse from their partners, for 
example, because their partners believe that they 
should not drink.
The review identified a total of 37 studies, 
providing 77 estimates of association between 
physical and/or sexual intimate partner violence 
and alcohol use.
Six longitudinal studies, with 10 estimates, 
examined whether intimate partner violence was 
associated with incident alcohol use. All of these 
longitudinal estimates showed a positive direction 
of association between intimate partner violence 
and incident alcohol use, although not all were 
statistically significant (72). The best estimate from 
the available literature is from a longitudinal study 
on women’s health in Australia, in which alcohol 
abuse was measured subsequent to disclosure of 
intimate partner violence. This study reported an 
OR of 1.82 (95% CI = 1.04 to 3.18) (73).
Overall, longitudinal studies illustrate that the 
relationship between alcohol use and violence 
is bidirectional. There is a positive association 
between women’s experience of intimate partner 
violence and subsequent alcohol use, as well as an 
association between alcohol use and subsequent 
intimate partner violence. Although the causal 
relationship between experience of intimate partner 
violence and alcohol consumption in women is 
far from clear, there is clear evidence that women 
with histories of violence consume more alcohol, 
and, conversely, that women who binge drink and 
consume alcohol in other harmful ways are more 
likely to report experiences of violence. It is also 
possible that both alcohol use and intimate partner 
violence can be attributed to another underlying 
issue, such as a mental health disorder or another 
substance use, which can increase women’s 
vulnerability to violence and to alcohol use. Public 
health programming needs to address alcohol use 
in prevention and treatment of intimate partner 
violence, and experiences of violence need to be 
addressed in alcohol misuse programmes.
Depression and suicide
Traumatic stress is thought to be the main 
mechanism that explains why intimate partner 
violence may cause subsequent depression and 
suicide attempts. Exposures to traumatic events 
can lead to stress, fear and isolation, which, 
in turn, may lead to depression and suicidal 
behaviour (74). Again, the relationship may be 
bidirectional: other studies suggest that women 
with severe mental health difficulties are more 
likely to experience violent victimization (75, 76). 
Developmental and early life exposures to violence 
and other traumas may also play an important role 
in predicting both violence and depression (77, 78).
Seventeen papers were identified, reporting on 16 
studies, giving a total of 36 163 participants, and 
containing 55 effect estimates (79). For violence 
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and incident depression, the pooled OR from 
six studies was 1.97 (95% CI = 1.56 to 2.48). 
There was some heterogeneity5 between studies 
(I2 = 50.4%, P = 0.073), but all estimates but one 
showed a positive direction of effect. Three studies 
(80–82) examined violence and subsequent suicide 
attempts. All three showed positive relationships; 
two were statistically significant and one was 
borderline significant. A pooled OR of 4.54 (95% 
CI = 1.78 to 11.61) was calculated from these three 
studies (80–82).
Non-fatal injuries
Intimate partner violence is associated with 
many health consequences, but the most direct 
effects are fatal and non-fatal physical injuries. 
It is estimated that approximately half of women 
in abusive relationships in the USA are physically 
injured by their partners, and that most of them 
sustain multiple types of injuries (83). The head, 
neck and face are the most common locations 
of injuries related to partner violence, followed 
by musculoskeletal injuries and genital injuries. 
Measurement of injuries resulting from intimate 
partner violence remains challenging for many 
reasons.
Unlike other health effects of violence, measuring 
the relative risk of injury among women 
experiencing intimate partner violence as 
compared to women with no partner violence is 
less relevant and generally not feasible. Practically 
speaking, studies do not quantify injuries among 
women who are not experiencing partner violence, 
and therefore relative risks were not presented or 
were not calculable in most of the studies. A more 
5. In meta-analyses, tests of heterogeneity (e.g. I2) are used 
to show how much the individual studies show variability as 
opposed to consistency of results across studies. Higher hetero-
geneity scores that are statistically significant indicate that the 
variability is not due to chance alone.
practical measure of interest in understanding the 
health effects of intimate partner violence is the 
prevalence of injury directly attributable to partner 
violence, not the relative rate of injury among 
women experiencing and not experiencing partner 
violence. The few studies for which this relative risk 
information was available were analysed, and the 
relative risk data are presented below. Population-
based surveys, such as the DHS in countries that 
included a module on intimate partner violence 
with questions inquiring about physical injuries 
due to violence, complement these sources of data 
and provide a more direct estimate of injuries due 
to violence. These population-based data can be 
considered a more reliable and valid data source 
for these purposes, since they capture treated 
as well as untreated injuries that can be directly 
attributable to partner violence (because of the 
wording used in the surveys, which asks women 
who have experienced intimate partner violence 
whether they sustained injuries from the violence). 
The self-reported nature of the results, and the 
potential recall bias when time has elapsed, can 
bias the findings; however, given the limitations of 
the different data sources, the population-based 
studies provide more direct estimates of better 
quality.
Hospital- and clinic-based data were not included 
in this analysis, since surveillance data from clinics 
or hospitals, when available, vastly underestimate 
injuries due to violence for several reasons: 
many women, regardless of health systems in 
their country, do not seek health care for injuries 
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caused by partner violence (84 ),6 and if they do, 
many or most hospitals do not collect perpetrator 
information. Furthermore, even when asked about 
perpetrators, women presenting with injuries due 
to partner violence may be reluctant to disclose the 
actual source of the injury, attributing the injury to 
some other cause.
Random effects meta-analysis was conducted to 
summarize the data extracted from the 11 papers 
and data from the 31 countries with population-
based data (85 ). The proportion of women with 
injuries due to intimate partner violence among 
all women who had experienced partner violence 
was 41.8% (95% CI = 34.0% to 49.6%; weighting 
based on inverse variance). The relative risk of 
injuries for women with and without intimate 
partner violence was calculated where data 
allowed (i.e. three studies (86–88) for which injury 
rates among women without and women with 
partner violence were presented), showing an 
OR of 2.92 (95% CI = 2.21 to 3.63). Despite the 
serious limitations in the published data, the results 
from the population-based studies added strength 
to the analysis, by analysing data from women in 
the general population. These results, indicating 
that among women experiencing intimate partner 
violence 42% were injured by their partners, 
shows the potentially enormous health burden for 
women as a result of injuries from intimate partner 
violence.
Fatal injuries (intimate partner homicides)
Two methods were used to obtain estimates of the 
proportion of male and female homicides where 
the perpetrator was an intimate partner. First, a 
6. Data from the WHO multi-country study on women’s health 
and domestic violence against women (21) confirmed this find-
ing, with data from 14 sites in 9 countries. While, on average, 
48% of women experiencing physical intimate partner violence 
claimed they needed health care for their injuries, only 36% 
actually sought health care for them.
systematic review of all published and unpublished 
studies released between 1 January 1994 and 
31 December 2011 found 2167 abstracts, of 
which 118 studies that examined the proportion of 
intimate partner homicides were included. Second, 
a survey was conducted among 169 countries with 
official data sources and relevant web pages or 
contact information to gather country- or regional-
level data on intimate partner homicide. Contact 
was made via e-mail with the country statistics 
offices, ministries of justice, home offices, or police 
headquarters, if relevant information could not 
be found on home pages. In total, 226 different 
studies and statistics were found, capturing 1121 
estimates across 65 countries from 1982 to 2011 
(89).
For the total estimates, the total numbers of 
homicides by intimate partners were added by 
sex and divided by the total homicides by sex. 
Since some estimates are skewed, the findings 
are reported in median percentages. Regional 
estimates are given according to WHO regions.
Across all countries with available data since 1982:
• the median prevalence of intimate partner 
homicide was approximately 13%, with as many 
as 38% of all murdered women (in contrast 
to 6% of all murdered men) being killed by an 
intimate partner;
• the median prevalence of intimate partner 
homicide among all murdered women was 
highest in the South-East Asia Region, with 
approximately 55%, and the high-income 
region, with approximately 41%, followed by 
the African Region (approximately 40%) and the 
Region of the Americas (approximately 38%).
The regional differences in intimate partner 
homicide may represent real differences in patterns 
of homicide and correspond with the cultural 
acceptability of violence against women and the 
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prevalence of intimate partner violence against 
women. However, the regional differences may 
also be closely correlated with the completeness 
and quality of data on homicides among countries 
and regions, as there is a lack of data on intimate 
partner homicide in low-income settings, especially 
in Asia and Africa, and a high amount of missing 
data on the victim–offender relationship in Latin 
America.
The prevalence rates of intimate partner homicide 
presented are likely to be underestimations, since 
the victim–offender relationship is often not known 
or reported. Over- or underestimations might have 
also occurred because the study was restricted to 
one estimate per country year, which was averaged 
if data for more than one year were available. In 
addition, the study favored national representative 
information over small-scale studies, which might 
have gone into more depth, for example through 
data triangulation, to establish the victim–offender 
relationship.
Table 6 summarizes the information on the effect 
sizes for selected health outcomes and intimate 
partner violence.
Health effects of exposure to non-
partner sexual violence
The health effects of non-partner sexual 
violence – in particular the mental health effects 
(depression, anxiety disorders, including PTSD) are 
often referred to in reports and discussions. This 
review showed that population-based evidence 
on the strength of these associations is extremely 
limited. Currently, most evidence comes from 
clinical research and observation, rather than 
from longitudinal or case-control studies. Where 
the associations are measured, reports of sexual 
violence by all types of perpetrators (intimate 
and non-intimate partners) are often combined 
and were therefore not included. The reviews of 
the health effects associated with non-partner 
sexual violence reveal the poor state of research 
and highlight the need for dedicated longitudinal 
studies. No single longitudinal study or systematic 
review was found for any of the health associations 
with non-partner sexual violence. It was also found 
that health outcomes were not well defined and 
both the limited number of studies and the huge 
variations in the definitions used meant it was not 
possible to carry out a meta-analysis. The reviews 
conducted for mental health outcomes and harmful 
use of alcohol associated with non-partner sexual 
violence are summarized in the text below and in a 
summary table (Table 7) at the end of this section.
Depression and anxiety
Five studies, all based in the USA, were found to 
report associations between non-partner sexual 
violence and depression/anxiety disorders.
All studies found a positive association, but 
these were not consistently significant, nor did 
they consistently adjust for relevant factors. A 
large female veteran study of 137 006 women 
by Kimerling et al. (90), using the diagnostic 
categories of the Diagnostic and statistical manual 
of mental disorders, 4th edition (DSM-IV) (91), 
reported an adjusted OR of 2.25 (95% CI = 2.10 
to 2.40), while a second, military-based study by 
Hankin et al. (92), using a shortened version of 
the Centre for Epidemiological Studies Depression 
scale (CES-D) (93) (11 items), reported an adjusted 
OR of 3.16 (95% CI = 2.68 to 3.72). The study by 
Kimerling et al. (90) adjusted for race, age, and 
knowing own medical/mental health condition, 
while the study by Hankin et al. (92) adjusted for 
age and educational level. It appears that neither 
of the two military studies adjusted for military 
trauma.
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The 1998 Women’s Survey (94 ) found a non-
significant association between non-partner 
sexual violence and a high score of depression 
symptoms (OR = 1.25; 95% CI = 0.61 to 2.59), 
which was measured using a subscale from the 
CES-D scale. The cut-off for the high score was not 
provided. However, the same study also measured 
the association with a physician diagnosis of 
depression and/or anxiety within the last 5 years, 
and a significant association was reported 
(OR = 2.59; 95% CI = 1.17 to 5.72). This study 
adjusted for age, race, marital status, education 
and income. A similar positive association 
between depression and anxiety was found in 
a study of 1336 female university employees 
(95 ). This study used a modified CES-D scale to 
measure depression, and anxiety was measured 
using nine items from the Profile of Mood States 
scale (96), with adjustments for race, age and 
occupation. Finally, a study among 174 female 
patients (97 ) attending an internal medicine clinic 
and using the Hopkins checklist (98), reported an 
association between non-partner sexual violence 
and depression, with an adjusted OR of 2.5 (95% 
CI = 1.63 to 7.48).
Alcohol use disorders
A limited body of research and differing definitions 
made it impossible to conduct a meta-analysis 
of the available results. The literature search 
resulted in five eligible studies. These were all 
cross-sectional studies (six papers) reporting 
associations between non-partner sexual violence 
and alcohol use disorders, and will be described 
briefly here. Three of the studies are from the 
USA (90, 92, 95, 99: references (95 ) and (99) are 
reports on the same study), one from Switzerland 
(100) and one from Lima, Peru (101). Two of the 
studies are based on military samples (90, 92), 
two on samples from workers (95, 99, 101), and 
the Swiss study was among adolescent girls, aged 
15 to 20 years, enrolled in schools or professional 
training programmes (100). All the studies except 
one (101) reported adjustments for variables such 
as age, race, occupation, employment income and 
marital status, while the study among workers 
also adjusted for work-related stress (99). 
The two military-sample studies did not report 
whether additional adjustments were made for 
work context, i.e. adjustments for military-related 
trauma.
There were many differences in what was 
considered as alcohol use problems in these 
studies, with the study by Kimerling et al. (90) 
reporting on alcohol use disorder, which was 
quantified according to the mental health and 
substance abuse clinical classification using the 
DSM-IV (88). Hankin et al. (92) measured “alcohol 
abuse”, which was quantified using the five-item 
TWEAK scale (an acronym for the five questions 
used [T – Tolerance, W – Worried, E – Eye opener, 
A – Amnesia – black-outs, K – K/Cut down].
Rospenda et al. (99), reporting on the sample 
of university workers, measured associations 
between non-partner sexual violence and “problem 
drinking”, using a combination of the Michigan 
Assessment Screening Test for Alcohol and Drugs 
scale (102) with one or more instances of drinking 
to intoxication and one or more instances of heavy 
episodic drinking. Heavy episodic drinking and 
drinking to intoxication was also measured in 
the study among adolescent girls (95 ), and was 
based on two questions. This study measured 
“drinking alcohol regularly”, but detail on how 
this was measured was not provided. Similarly, 
the study among workers in Lima (101) presented 
measures of association between non-partner 
sexual violence with alcohol consumption but no 
detail was provided on how alcohol consumption 
was measured.
All six papers reported positive associations with 
non-partner sexual violence, with five reporting 
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Table 6. Summary of effect size estimates for selected health outcomes and intimate partner violence
Domain Disease/injury 
resulting from 
violence
Definition Search date Number 
of studies 
identified
Effect size  
(95% CI)a
Sexual 
health
HIV/AIDS Infection with HIV, with or 
without progression to AIDS
December 2010 17 OR = 1.52b (1.03 to 2.23)
Syphilis infection Acute and chronic infection 
with Treponema pallidum
December 2010 21 aOR = 1.61c (1.24 to 
2.08)
Chlamydia or 
gonorrhoea
Bacterial infection with 
Chlamydia trachomatis, 
transmitted vaginally, anally 
or perinatally;d Bacterial 
infection with Neisseria 
gonorrhoea, transmitted 
vaginally, anally or perinatally
December 2010 21 OR = 1.81e (0.90 to 3.63)
Reproductive 
health
Induced abortion Episodes of induced abortion December 2011 31 OR = 2.16f (1.88 to 2.49)
Perinatal 
health
Low birth weight < 2500 g June 2012 13 aOR = 1.16g (1.02 to 
1.29)
Premature birth Gestational age < 37 weeks June 2012 10 aOR = 1.41g (1.97 to 
2.60)
Small for gestational 
age
Birth weight below the 10th 
percentile
June 2012 3 aOR = 1.36g (0.53 to 
2.19)
Mental 
health
Unipolar depressive 
disorders
Depressive episodes February 2013 16 OR = 1.97h (1.56 to 2.48)
Alcohol use 
disorders
Alcohol use disorders; 
authors’ definitions
January 2011 36 OR = 1.82i (1.04 to 3.18)
Injuries Any injury inflicted 
by partner
Injuries inflicted by partner September 
2011
11 papers 
+ data 
from 31 
countries
42% of women with 
intimate partner violence 
were injured by their 
partner (34% to 49.6%)j
2.92k (2.21 to 3.63), 
comparing injuries 
among women with and 
without intimate partner 
violence
Death Homicide Death perpetrated by partner December 2011 226 Approximately 13% of 
all murders, 38% of all 
female murders and 6% 
of all male murdersl
Suicide Death perpetrated by self November 2011 3 OR = 4.54m (1.78 to 
11.61)
a Effect size refers to the estimate of association and 
is based on either a best estimate from the literature 
or a pooled estimate from a meta-analysis.
b Best estimate (58).
c Best estimate (63).
d Excludes ocular trachoma.
 e Best estimate (59).
f Pooled estimate (70).
g Pooled estimate (71).
h Pooled estimate from 6 studies (79).
i Best estimate (73).
j Pooled estimate (85).
k Pooled estimate from 3 studies (86–88).
l Pooled estimate (89).
m Pooled estimate (79)
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significant associations: alcohol disorders OR = 2.33 (95% CI = 2.15 to 2.53) (90); alcohol 
consumption OR = 1.92 (95% CI = 1.62 to 2.38) (101); drinking to intoxication OR = 1.72 (95% 
CI = 1.26 to 2.36) (95 ); alcohol abuse OR = 1.89 (95% CI = 1.27 to 2.60) (92); and drinking 
alcohol regularly OR = 1.95 (95% CI = 1.5 to 2.5) (100). Despite the limitation of the estimates, 
it is clear that non-partner sexual violence is associated with problem alcohol use. In the 
absence of a pooled estimate, the estimate of “alcohol disorders” was used, which was based 
on the largest sample (n = 134 894) and which was also based on the DSM-IV (91) clinical 
classification of mental health disorders and conditions.
Table 7 summarizes the effect size for depression and alcohol use disorders and non-partner 
sexual violence against women.
Table 7. Summary of effect size estimates for depression and alcohol use disorders and non-
partner sexual violence
Domain Disease/injury 
resulting from 
violence
Definition Search date Number 
of studies 
identified
Effect size 
(95% CI)a
Mental health Unipolar 
depressive 
disorders 
combined with:
Depressive 
episodes
May 2012 5 OR = 2.59b 
(1.17 to 5.72)
Anxiety disorders Including PTSD 
and obsessive–
compulsive 
disorder
May 2012
Alcohol use 
disorders
May 2012 5 OR = 2.33c 
(2.15 to 2.53)
a Effect size refers to the estimate of association and is based on either a best estimate from the literature.
b Best estimate (94).
c Best estimate (90).
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The findings highlight that intimate partner violence 
is a major contributor to women’s mental health 
problems, particularly depression and suicidality, 
as well as to sexual and reproductive health 
problems, including maternal health and neonatal 
health problems.
Globally 35.6% have experienced either intimate 
partner violence and/or non-partner sexual 
violence. Nearly one third of ever-partnered women 
(30.0%) have experienced physical and/or sexual 
violence by an intimate partner, and 7.2% of adult 
women have experienced sexual violence by a non-
partner. Some women have experienced both.
Key findings on health outcomes of physical and 
sexual intimate partner violence include:
• globally, as many as 38% of all murders of 
women are reported as being committed by 
intimate partners;
• 42% of women who have been physically and/or 
sexually abused by a partner have experienced 
injuries as a result of that violence;
• women who have experienced partner violence 
have higher rates of several important health 
problems and risk behaviours; compared to 
women who have not experienced partner 
violence, they:
 – have 16% greater odds of having a low-birth-
weight baby;
 – are more than twice as likely to have an 
induced abortion;
 – are more than twice as likely to experience 
depression;
• in some regions, they are 1.5 times more likely 
to acquire HIV, and 1.6 times more likely to have 
syphilis,7 compared to women who do not suffer 
partner violence.
7. This association was found for sexual intimate partner 
violence only.
Summary of findings
This comprehensive review of the prevalence and 
health effects of two forms of violence against 
women (intimate partner violence and non-partner 
sexual violence) marks an important milestone, 
not only in the field of research in violence against 
women, but also in the field of public health in 
general. This report presents the first global and 
regional prevalence estimates of physical and 
sexual intimate partner violence against women, 
and non-partner sexual violence against women, 
using evidence from comprehensive systematic 
reviews of global population data.
The findings confirm the fact that intimate partner 
violence and non-partner sexual violence are 
widespread and affect women throughout the 
world. Despite this evidence, many still choose 
to view the violent experiences of women as 
disconnected events, taking place in the private 
sphere of relationship conflict and beyond the 
realm of policy-makers and health-care providers. 
Others blame the women themselves for being 
subjected to violence, rather than the perpetrators. 
In the case of non-partner sexual violence, women 
are blamed for deviating from accepted social 
roles, for being in the wrong place, or for wearing 
the wrong clothes. In the case of partner violence, 
women are blamed for talking to another man, 
refusing sexual intercourse, not asking permission 
from their partner (e.g., for going out, visiting their 
family), or for not conforming to their role as wives/
partners in some other way.
The health sector in particular has been slow to 
engage with violence against women. Yet, this 
report presents clear evidence that exposure to 
violence is an important determinant of poor health 
for women. This is in spite of the fact that this 
report has only looked at a limited set of health 
outcomes.
Section 4: Summary and conclusions
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The review confirms the degree to which women 
with violent partners may be injured. However, 
despite injury often being perceived to be one of 
the outcomes of intimate partner violence, the 
reviews found surprisingly limited data on this 
issue, with gaps in population data, particularly 
on the extent and forms of injury that women 
experience in different settings.
While, across regions, there are consistently 
higher rates of intimate partner violence than non-
partner sexual violence, this does not indicate that 
non-partner sexual violence should be given less 
attention or be seen as less significant to women’s 
health. We know that sexual violence remains 
highly stigmatized, and carries heavy social 
sanctions in many settings. Furthermore, given the 
sensitivities of reporting sexual violence, we know 
these estimates are likely to underestimate actual 
prevalence. While measures of partner violence 
capture a spectrum of acts of physical, sexual and 
psychological8 violence, ranging from less severe to 
the most severe forms of violence, sexual violence, 
by definition, is among the most severe forms of 
violence.
The fact that, in spite of the constraints to 
reporting, 7.2% of women globally have reported 
non-partner sexual violence provides important 
evidence of the extent of this problem. This review 
found that women who have experienced non-
partner sexual violence are 2.3 times more likely 
to have alcohol use disorders and 2.6 times more 
likely to have depression or anxiety than women 
who have not experienced non-partner sexual 
violence.
This is supported by clinical experience, which 
shows that sexual violence can profoundly affect 
8. This review did not include psychological/emotional violence, 
as there are fewer data available and much more variation in 
how this is measured across studies.
physical and mental health in the short and long 
term, contributing to the burden of ill health 
among survivors. Some studies have shown that 
women who have been raped have higher rates 
of use of medical care (e.g. visits to the doctor, 
hospitalizations) compared to women who have 
not been raped, even years after the event (103). 
These data also highlight the need to find better 
ways to help the survivors of sexual violence and 
prevent more women and girls from suffering these 
experiences in the first place.
Limitations of the review
The review was constrained by the availability 
of data, and, in particular, of data of sufficient 
quality to assess the health burden of both 
intimate partner violence and sexual violence by 
perpetrators other than partners. It also only looked 
at a selected number of health outcomes, and was 
unable to assess the level of comorbidity; women 
suffering intimate partner violence, in particular, 
are likely to be experiencing more than one health 
outcome at a point in time.
The estimates of prevalence and health burden 
were limited to physical and sexual intimate 
partner violence and did not include emotional/
psychological abuse, even though qualitative 
research shows this to be an important element 
of intimate partner violence, which many women 
report as being particularly disabling and resulting 
in ill health. There is a need to strengthen 
methodologies for measuring this type of violence, 
testing them cross-culturally and developing 
consensus on them.
The review has highlighted the data gap in relation 
to non-partner sexual violence, and, in particular, 
the need for improving the way in which results 
from studies of sexual violence  are reported. 
This is most evident in the absence of population 
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data from conflict settings, in spite of the growing 
attention to this issue.
This report also only considers measures of 
sexual violence among women aged 15 years or 
more. If sexual violence in all of its forms – by 
all perpetrators (partners and non-partners), 
during childhood and adulthood – were measured 
together, the prevalence rates would be much 
higher than those found here. Evidence also shows 
that women who have experienced one form of 
violence are more likely to experience another 
episode of violence, which would not be captured 
in an aggregated measure of sexual violence. 
While the global and regional prevalence estimates 
presented in this report are an important step in 
documenting the epidemiology of this public health 
problem, more information is needed to understand 
and document sexual violence more accurately.
This report has sought to quantify the health 
burden, but the bidirectional relationship with many 
factors makes this difficult, in the absence of high-
quality longitudinal data where both the exposures 
to violence and the health outcomes are measured 
at multiple time points.
The number of health outcomes that were included 
in this review was limited for methodological, time 
and resource reasons. An important omission 
from the review was evidence on the relationship 
between exposures to intimate partner violence 
and noncommunicable diseases. There is 
research indicating a relationship with chronic 
conditions, including cardiovascular disease 
and hypertension (104 ) and we are beginning to 
understand better the potential pathways that 
explain these relationships (105 ). However, this 
was not addressed in this review. The review did 
look at the relationship with harmful use of alcohol, 
which, together with smoking (also not addressed 
in this review), is associated with cardiovascular 
and other noncommunicable diseases. The review 
also did not discuss the compelling literature on 
the effects of partner violence on child health 
and developmental and behavioural outcomes 
(106–109).
Implications of the findings
Research gaps
This work and these findings highlight several 
research gaps that must be noted in the 
interpretation of these data and that should inform 
future research.
First, the prevalence estimates highlight several 
gaps in population-based data. Many countries 
have not collected population-based data on either 
intimate partner violence or non-partner violence, 
and the prevalence rates for these countries are 
unknown. This was most evident in the total 
lack of data from the Eastern Mediterranean 
Region on non-partner sexual violence, making it 
impossible to calculate an estimate for this region. 
Looking at the regions in more detail (See Table 
A.2.1), the regions with the least data available 
on intimate partner violence were Central Sub-
Saharan Africa, East Asia, Caribbean and Central 
Asia. Countries that do have data often base their 
estimates on inadequate survey instruments or 
methodologies. The gold standard for valid data on 
violence against women is currently a stand-alone 
specialized survey, such as the WHO multi-country 
study on women’s health and domestic violence 
against women (21), with adequate measures 
taken to address the ethical and safety issues 
that are unique to this type of research. These 
measures include specialized training of female 
interviewers to collect data in a private space, 
in a non-judgmental manner, in the absence of 
male partners; provision of referrals if necessary; 
and interviewing only one woman per household, 
to prevent knowledge about the survey content 
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being shared. The training of interviewers is also 
critical and when this is done appropriately, women 
are more likely to disclose their experiences of 
all forms of violence and are more likely to feel 
supported in their disclosure, particularly when 
adequate safety measures are taken. Other 
surveys, such as DHS also provide some of these 
safety measures when using the violence against 
women module but, in general, violence modules 
added to other surveys tend to achieve lower 
disclosure rates, thereby reducing the overall 
prevalence rates documented.
Second, less is known about how to capture 
experiences of sexual violence. Questions on 
intimate partner violence have received more 
attention and the measurement of partner 
violence is more advanced in terms of which 
questions to ask and how to capture exposure to 
partner violence, particularly physical and, less 
so, sexual partner violence. Revisions have been 
made or are under way in several large violence 
survey instruments (4, 21), which will improve 
measurement, and can serve as a model for other 
surveys on violence. It is less clear whether the 
current questions used to capture experiences of 
non-partner sexual violence adequately capture the 
range of these experiences. Not only do the actual 
questions on sexual violence need improvement 
and further validation, but multiple experiences 
and multiple perpetrators over different time 
periods are important aspects of sexual violence 
that also need to be captured adequately. These 
measurement issues are particularly relevant for 
conflict settings, where this review has shown a 
large gap in robust data.
Third, it is important to note that differences 
in political and cultural factors mean that 
individual countries need their own data, and that 
extrapolating one country’s prevalence estimates 
to another is not necessarily appropriate for 
policy and programmatic decision-making. So, 
while two countries might share a border and 
might have cultural and other similarities, and the 
experience of violence against women may be 
assumed to be the same in the two places, each 
country will need to collect its own data, in order 
to understand the risk factors related to violence 
against women in that particular context and to 
respond appropriately. Collecting sound data on the 
magnitude and nature of the problem has served 
in many countries as a stimulus to acknowledge 
and name the problem and initiate discussions on 
policies and strategies to address it. This will also 
provide a baseline against which countries can 
measure progress.
Finally, the data on health effects are 
predominantly based on cross-sectional studies, 
although the analyses in this report preferentially 
used effect estimates from longitudinal research, 
where these were available. Proving causality 
without establishing temporality is not possible, 
although other evidence is provided to support 
a causal hypothesis for these outcomes. For 
example:
• the causal pathways outlined in the conceptual 
framework in Figure 1 provide theoretical 
grounding in biological and behavioural 
mechanisms through which intimate partner 
violence can lead to selected health outcomes;
• the review replicates findings in a variety of 
settings, using population-based surveys;
• the review establishes temporal relationships 
for some of the findings, such as some of the 
studies in the intimate partner violence and 
abortion analysis and the intimate partner 
violence and low birth weight/prematurity 
analyses, since pregnancy outcomes were 
recorded by researchers at the time of the study 
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and reports of partner violence would have 
preceded these outcomes;
• in some of the analyses, the review establishes 
a dose–response association, with more severe 
outcomes found among more severely abused 
women;
• most importantly, the review finds strong, 
statistically significant associations when data 
are pooled for each of these outcomes, even 
after adjusting for confounding factors.
The review has maximized the use of the available 
data, but stronger conclusions could be made if 
more longitudinal data were available, if biological 
markers were available for some health issues, and 
if more studies controlled for relevant confounding 
factors. Better study designs would enable greater 
understanding of the nature of the health effects of 
intimate partner violence and non-partner sexual 
violence.
Conclusions
In light of these data, in which more than one 
in three women (35.6%) globally report having 
experienced physical and/or sexual partner 
violence, or sexual violence by a non-partner, the 
evidence is incontrovertible – violence against 
women is a public health problem of epidemic 
proportions. It pervades all corners of the 
globe, puts women’s health at risk, limits their 
participation in society, and causes great human 
suffering.
The findings underpin the need for the health 
sector to take intimate partner violence and 
sexual violence against women more seriously. 
All health-care providers should be trained to 
understand the relationship between violence 
and women’s ill health and to be able to respond 
appropriately. Multiple entry points within the 
health sector exist where women may seek health 
care – without necessarily disclosing violence 
– particularly in sexual and reproductive health 
services (e.g. antenatal care, post-abortion care, 
family planning), mental health and emergency 
services. The new WHO guidelines for the health 
sector response to intimate partner violence and 
sexual violence (110) emphasize the urgent need 
to integrate these issues into undergraduate 
curricula for all health-care providers, as well as in 
in-service training.
In relation to sexual violence, whether by a partner 
or non-partner, access to comprehensive post-rape 
care is essential, and must ideally happen within 
72 hours. The new WHO guidelines (110) describe 
this as including first-line psychological support, 
emergency contraception, prophylaxis for HIV, 
diagnosis and prophylaxis for other STIs, and short- 
and long-term mental health support. This should 
also include access to collection and analysis of 
forensic evidence for those women who choose to 
follow a judicial procedure. Similarly, for intimate 
partner violence, access to first-line psychological 
support, mental health and other support services 
needs to be developed and strengthened.
This health sector response needs to be part of 
a multisectoral response, as recently endorsed 
in the Agreed Conclusions of the 57th session of 
the Commission on the Status of Women (2). The 
Commission makes recommendations for and 
urges governments and other actors, at all levels, 
to:
• strengthen the implementation of legal and 
policy frameworks and accountability;
• address structural and underlying causes and 
risk factors, in order to prevent violence against 
women and girls;
• strengthen multisectoral services, programmes 
and responses to violence against women and 
girls.
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The high prevalence of these forms of violence 
against women globally, and in all regions, also 
highlights the need to go beyond services and 
the importance of working simultaneously on 
preventing this violence from happening in the 
first place. The variation in the prevalence of 
violence seen within and between communities, 
countries and regions highlights that violence is not 
inevitable, and that it can be prevented.
There is growing evidence about the factors that 
explain much of the global variation. This evidence 
highlights the need to address the economic 
and sociocultural factors that foster a culture of 
violence against women. Promising prevention 
programmes exist, particularly for intimate partner 
violence, and need to be tested and scaled up. 
Interventions for prevention include: challenging 
social norms that support male authority and 
control over women and that condone violence 
against women; reducing levels of childhood 
exposure to violence; reforming discriminatory 
family law; strengthening women’s economic 
rights; eliminating gender inequalities in access to 
formal wage employment and secondary education 
(111, 112); and, at an individual level, addressing 
harmful use of alcohol. Growing evidence from 
surveys of men asking about perpetration of rape/
sexual assault against non-partners, and physical 
and sexual violence against partners, also points 
to the need to address social and cultural norms 
around masculinity, gender power relationships and 
violence. (113, 114)
This report unequivocally demonstrates that 
violence against women is pervasive globally and 
that it is a major contributing factor to women’s 
ill health. In combination, these findings send a 
powerful message that violence against women 
is not a small problem that only occurs in some 
pockets of society, but rather is a global public 
health problem of epidemic proportions, requiring 
urgent action. As recently endorsed by the 
Commission on the Status of Women (2), it is time 
for the world to take action: a life free of violence 
is a basic human right, one that every woman, man 
and child deserves.
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Table A1.1. Countries included in intimate partner violence prevalence estimates by WHO region
WHO region Countries
Low- and middle-income regions:
Africa Botswana, Cameroon, Democratic Republic of the Congo, Ethiopia, 
Kenya, Lesotho, Liberia, Malawi, Mozambique, Namibia, Rwanda, 
South Africa, Swaziland, Uganda, United Republic of Tanzania, 
Zambia, Zimbabwe
Americas Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador,  
El Salvador, Haiti, Honduras, Jamaica, Mexico, Nicaragua, 
Paraguay, Peru, Plurinational State of Bolivia
Eastern Mediterranean Egypt, Iran, Iraq, Jordan, Palestinea
Europe Albania, Azerbaijan, Georgia, Lithuania, Republic of Moldova, 
Romania, Russian Federation, Serbia, Turkey, Ukraine
South-East Asia Bangladesh, Timor-Leste (East Timor), India, Myanmar, Sri Lanka, 
Thailand
Western Pacific Cambodia, China, Philippines, Samoa, Viet Nam
High incomeb Australia, Canada, Croatia, Czech Republic, Denmark, Finland, 
France, Germany, Hong Kong,a Iceland, Ireland, Israel, Japan, 
Netherlands, New Zealand, Norway, Poland, South Korea, Spain, 
Sweden, Switzerland, United Kingdom of Great Britain and 
Northern Ireland, United States of America
a Data from this territory (not a WHO Member State) were included in the regional estimates.
b High-income countries are classified by the World Bank based on the gross national income per capita calculated using  
the World Bank Atlas method (115 ).
Appendix 1: Countries included by WHO region and 
age group
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Table A1.2. Countries included in non-partner sexual violence prevalence estimates by WHO region
WHO region Countries
Low- and middle-income regions:
Africa Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, 
Kenya, Liberia, Malawi, Mozambique, Namibia, Nigeria, Sierra Leone, 
South Africa, Uganda, United Republic of Tanzania, Zambia, Zimbabwe
Americas Argentina, Belize, Brazil, Costa Rica, Jamaica, Nicaragua, Peru, 
Uruguay 
Eastern Mediterranean
Europe Azerbaijan, Kazakhstan, Kosovo, Lithuania, Serbia, Turkey, Ukraine
South-East Asia Bangladesh, Timor-Leste (East Timor), India, Maldives, Sri Lanka, 
Thailand
Western Pacific Kiribati, Philippines, Samoa
High incomea Australia, Canada, Czech Republic, Denmark, Finland, Germany, Hong 
Kong,b Isle of Man,b Japan, New Zealand, Poland, Spain, Sweden, 
Switzerland, United Kingdom of Great Britain and Northern Ireland, 
United States of America
a High-income countries are classified by the World Bank based on the gross national income per capita calculated using the 
World Bank Atlas method (115 ).
b Data from this territory (not a WHO Member State) were included in the regional estimates.
46 Global and regional estimates of violence against women
Table A1.3. Number of estimates included in analysis of intimate partner violence by WHO 
region and age group
Low and middle-income regions
Age 
group, 
years
Africa Americas Eastern 
Mediterranean
Europe Western 
Pacific
South-
East 
Asia
High 
income
Total
15–19 44 60 9 29 12 16 28 198
20–24 44 59 7 15 20 16 38 199
25–29 42 59 8 29 18 16 34 206
30–34 44 60 9 31 20 16 36 216
35–39 5 18 2 8 11 1 28 73
40–44 2 13 2 6 6 1 4 34
45–49 42 59 7 10 26 16 31 191
50–54 0 4 1 0 6 0 2 13
55–59 0 4 0 0 0 0 3 13
60–64 2 0 0 0 0 0 5 7
65–69 3 3 1 0 3 0 23 33
Table A1.4. Number of estimates included in analysis of intimate partner violence by region for 
all ages combined
Low and middle-income regions
Age 
group
Africa Americas Eastern 
Mediterranean
Europe Western 
Pacific
South-
East 
Asia
High 
income
Total
All ages 
combined
71 72 18 50 33 34 114 392
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Intimate partner violence
When the prevalence data are grouped by the 21 regions used in the 2010 Global Burden of Disease (GBD) 
study, a more nuanced picture appears. The highest prevalence is found in central sub-Saharan Africa, 
where a prevalence of 65.6% of ever-partnered women have experienced intimate partner violence. All 
regions of sub-Saharan Africa are above the global average of 26.4%. The lowest prevalence is in East Asia, 
with 16.3% of ever-partnered women reporting intimate partner violence. The only other regions below the 
global average are high-income Western Europe (19.3%), North America (21.3%), Central Asia (22.9%) and 
Southern Latin America (23.7%). The remaining countries have a prevalence of 26% or above. It is important 
to note that even in the case of the below-average regions, between one quarter and one fifth of ever-
partnered women have still experienced partner violence.
Table A.2.1. Prevalence of intimate partner violence by GBD region
Region Prevalence (95% confidence interval), %
Asia Pacific, High Income 28.45 (20.6 to 36.3)
Asia, Central 22.89 (15.8 to 30.0)
Asia, East 16.30 (8.9 to 23.7)
Asia, South 41.73 (36.3 to 47.2)
Asia, South-East 27.99 (23.7 to 32.2)
Australasia 28.29 (22.7 to 33.9)
Caribbean 27.09 (20.8 to 33.3)
Europe, Central 27.85 (22.7 to 33.0)
Europe, Eastern 26.13 (20.6 to 31.6)
Europe, Western 19.30 (15.9 to 22.7)
Latin America, Andean 40.63 (34.8 to 46.5)
Latin America, Central 29.51 (24.6 to 34.4)
Latin America, Southern 23.68 (12.8 to 34.5)
Latin America, Tropical 27.43 (20.7 to 34.2)
North Africa/Middle East 35.38 (30.4 to 40.3)
North America, High Income 21.32 (16.2 to 26.4)
Oceania 35.27 (23.8 to 46.7)
Sub-Saharan Africa, Central 65.64 (53.6 to 77.7)
Sub-Saharan Africa, East 38.83 (34.6 to 43.1)
Sub-Saharan Africa, Southern 29.67 (24.3 to 35.1)
Sub-Saharan Africa, West 41.75 (32.9 to 50.6)
Appendix 2: Prevalence estimates of violence 
against women by Global Burden of Disease regions
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Non-partner sexual violence
This section presents additional data on the prevalence estimates of non-partner sexual violence, grouped 
by the 21 regions from the GBD 2010 study. There were variations across the regions, with the prevalence 
ranging between 3.3% and 21.0%. The highest prevalence was reported in the sub-Saharan Africa, Central 
region (21%) followed by the sub-Saharan Africa Southern (17.4%) region. The large confidence interval 
in the sub-Saharan Africa, Central region is most likely due to this being based on a single estimate. The 
lowest estimate was reported in the Asia South region (3.3 %), followed by the North Africa/Middle East 
region (4.5%).
Table A.2.2. Prevalence of non-partner sexual violence by GBD region 
Region Prevalence (95% confidence interval), %
Asia Pacific, High Income 12.20 (4.21 to 20.19)
Asia, Central 6.45 (0 to 13.0)
Asia, East 5.87 (0.15 to 11.59)
Asia, South 3.35 (0 to 8.37)
Asia, South-East 5.28 (0.94 to 9.61)
Australasia 16.46 (11.52 to 21.41)
Caribbean 10.32 (3.71 to 16.92)
Europe, Central 10.76 (6.14 to 15.38)
Europe, Eastern 6.97 (0 to 14.13)
Europe, Western 11.50 (7.24 to 15.76)
Latin America, Andean 15.33 (10.12 to 20.54)
Latin America, Central 11.88 (7.31 to 16.45)
Latin America, Southern 5.86 (0.31 to 11.42)
Latin America, Tropical 7.68 (2.68 to 12.69)
North Africa/Middle East 4.53 (0 to 12.74)
North America, High Income 13.01 (9.02 to 16.99)
Oceania 14.86 (7.48 to 22.24)
Sub-Saharan Africa, Central 21.05 (4.59 to 37.51)
Sub-Saharan Africa, East 11.46 (7.31 to 15.60)
Sub-Saharan Africa, Southern 17.41 (11.48 to 23.33)
Sub-Saharan Africa, West 9.15 (4.90 to 13.41)
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Regression function to estimate regional levels of intimate partner violence
Intercept is omitted in the model:
Prevalencei = β1*subnational + β2*physvio + β3*sexvio + β4*pastyr + β5*severity + 
β6*notviostudy + β7*nointrain + β8*pstatus + β9*region1 +… + β15*region7 + μi
where μi is the residual for the i:th study estimate, and the dummy variables are coded as:
• subnational = 0 if national, 1 if subnational;
• physvio = 0 if physical and/or sexual intimate partner violence, 1 if physical violence only;
• sexvio = 0 if physical and/or sexual intimate partner violence, 1 if sexual violence only;
• pastyr = 0 if lifetime exposure to intimate partner violence, 1 if past-year violence only;
• severity = 0 if any form of intimate partner violence, 1 if severe violence only;
• notviostudy = 0 if study designed to measure violence, 1 if study not indented to measure violence;
• nointrain = 0 if interviewers trained, 1 if not trained;
• pstatus = 0 if ever-partnered women included, 1 if only currently partnered women included;
• region1 to region7 are coded as 1 if study from corresponding region, 0 otherwise.
Regression function to estimate age-group-specific regional levels of 
intimate partner violence
Intercept is omitted in the model:
Prevalencei = β1*subnational + β2*physvio + β3*sexvio + β4*pastyr + β5*severity + 
β6*notviostudy + β7*nointrain + β8*pstatus + βjk*regioni*agegroupk + μi 
where region j*agegroupk denotes all main effects and interactions for all the combinations of regions and 
age groups, μi is the residual for the i:th study estimate, and the dummy variables are coded above.
Appendix 3: Regression models for calculating 
regional estimates of intimate partner violence
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Regression function to estimate regional levels for non-partner sexual violence
Intercept is omitted in the model:
Prevalencei = β1*subnational + β2*nointrain + β3*allnonpartners + β4*region1  
+ ... + β11*region7 + μi 
where μi is the residual for the i:th study estimate, and the dummy variables are coded as:
• subnational = 0 if national, 1 if subnational;
• nointrain = 0 if interviewers trained, 1 if not trained;
• allnonpartners = 0 if not all nonpartners included, 1 if all nonpartners included;
• region1 to region7 are coded as 1 if study from corresponding region, 0 otherwise.
